Kessler helps convict Pfizer of racketeering

Share this article:
Based in part on testimony from former FDA commissioner David Kessler, a Massachusetts federal jury has found Pfizer guilty of violating racketeering laws in marketing its epilepsy drug Neurontin. The jury said the company should pay $142.1 million in damages.

In the case, Kaiser Foundation Health Plan and Kaiser Foundation Hospitals said Pfizer illegally promoted Neurontin for unapproved uses. A Kaiser attorney said the jury found that Pfizer engaged in a racketeering conspiracy for 10 years, a determination that he said should help in future Neurontin cases.

Kaiser claimed it was forced to pay $90 million more than it should have for Neurontin, believing that migraines and bipolar disorder were among conditions it could treat effectively.

Several jurors said they were influenced by Kessler's testimony on behalf of Kaiser along with testimony by Johns Hopkins epidemiologist Kay Dickerson. Dickerson's article casting doubt on Neurontin clinical studies appeared in 2009.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters